Reversal of the reserpine syndrome with L-dopa metabolites in reserpinized rats.
D000818:Animals; D002490:Central Nervous System / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000627:therapeutic use*; D009048:Motor Skills / Q000187:drug effects; D009069:Movement Disorders / Q000139:chemically induced* / Q000188:drug therapy / Q000378:metabolism; D009647:Normetanephrine / Q000627:therapeutic use; D051381:Rats; D012110:Reserpine / Q000009:adverse effects*; D014443:Tyrosine / Q000378:metabolism
D009647:Normetanephrine; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D012110:Reserpine